Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01022645 · ClinicalTrials.gov registry record
Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 42
- Enrollment target
NCT01022645 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 42 participants.
The verdict
NCT01022645 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The study is being done in order to gain information on the most suitable types of birth control in women who recently had gestational diabetes, or diabetes diagnosed during pregnancy. The intrauterine device (IUD) is a highly effective form of birth control. It is inserted into the uterus and prevents pregnancy for either 5 or 10 years, depending on the type of IUD (hormone-releasing or copper). The hormone-releasing IUD works for 5 years and releases a hormone called a progestin into the uterus. The copper IUD contains no hormones and works for 10 years. The IUD is an excellent form of birth control postpartum, but it is unknown if the hormone-releasing IUD will affect blood sugars and increase a woman's risk of becoming diabetic when she's not pregnant. The hypothesis is that the hormone-containing IUD will NOT increase blood sugars, so women who use the hormone-containing IUD will have similar blood sugars to those who use the copper IUD or have had their tubes tied (no hormones).
Interventions
- DEVICE Mirena (Levonorgestrel IUD)
- DEVICE Paragard (Copper IUD ) or Tubal Ligation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01022645
The ClinicalTrials.gov registry entry for NCT01022645 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mirena (Levonorgestrel IUD) is the first listed.
NCT01022645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01022645 about?
NCT01022645 is a clinical study titled "Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes". The study is being done in order to gain information on the most suitable types of birth control in women who recently had gestational diabetes, or diabetes diagnosed during pregnancy. The intrauterine device (IUD) is a highly effective form of birth control. It is inserted into the uterus and preve...
What is the current status of trial NCT01022645?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2009-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01022645?
The interventions under investigation include: Mirena (Levonorgestrel IUD) (DEVICE), Paragard (Copper IUD ) or Tubal Ligation (DEVICE).
Who is sponsoring clinical trial NCT01022645?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.